|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Center for Neurodegenerative Disease Research, Institute on Aging and Department of Pathology and Laboratory Medicine (A.S.C.-P., W.Y., E.M.W., C.M.C., V.M.-Y.L., J.Q.T., V.M.V.D.), and Department of Neurology (A.S.C.-P., C.A., H.I.H., C.M.C., M.G.), University of Pennsylvania School of Medicine, Philadelphia; and Department of Neurology (B.L.M.), University of California San Francisco.
* To whom correspondence should be addressed. E-mail: vivianna{at}mail.med.upenn.edu.
ABSTRACT
Background: Mutations in the LRRK2 gene are an important cause of familial and nonfamilial parkinsonism. Despite pleomorphic pathology, LRRK2 mutations are believed to manifest clinically as typical Parkinson disease (PD). However, most genetic screens have been limited to PD clinic populations.
Objective: To clinically characterize LRRK2 mutations in cases recruited from a spectrum of neurodegenerative diseases.
Methods: We screened for the common G2019S mutation and several additional previously reported LRRK2 mutations in 434 individuals. A total of 254 patients recruited from neurodegenerative disease clinics and 180 neurodegenerative disease autopsy cases from the University of Pennsylvania brain bank were evaluated.
Results: Eight cases were found to harbor a LRRK2 mutation. Among patients with a mutation, two presented with cognitive deficits leading to clinical diagnoses of corticobasal syndrome and primary progressive aphasia.
Conclusion: The clinical presentation of LRRK2-associated neurodegenerative disease may be more heterogeneous than previously assumed.
This article has been cited by other articles:
![]() |
S. Lesage and A. Brice Parkinson's disease: from monogenic forms to genetic susceptibility factors Hum. Mol. Genet., April 15, 2009; 18(R1): R48 - R59. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Marin, W. N. van Egmond, and P. J. M. van Haastert The Roco protein family: a functional perspective FASEB J, September 1, 2008; 22(9): 3103 - 3110. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Ross, M. Toft, K. Haugarvoll, A. Chen-Plotkin, W. Yuan, C. Anderson, E. M. Wood, H.I. Hurtig, C. Clark, B.L. Miller, et al. CORTICOBASAL SYNDROME AND PRIMARY PROGRESSIVE APHASIA AS MANIFESTATIONS OF LRRK2 GENE MUTATIONS Neurology, July 22, 2008; 71(4): 303 - 304. [Full Text] [PDF] |
||||
![]() |
Nonparkinsonian Diseases Caused by LRRK2 Mutations Journal Watch Neurology, June 17, 2008; 2008(617): 4 - 4. [Full Text] |
||||
Read all Correspondence
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |